GC Biopharma to Conduct Phase 3 Clinical Trial for Two-Dose Chickenpox Vaccine in South Korea
GC Biopharma’s chickenpox vaccine, Barycela Inj., is set to enter a Phase 3 clinical trial in South Korea to confirm evidence supporting a two-dose...
Search results for "two-dose schedule"
Think All Health Screenings Are Equal? What Happens After the Results Is What Really Counts
"What else should I add to my checkup this year. " It is a question clinicians hear continuously as patients schedule their annual health screenings.
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
Don't Take All Your Supplements at Once: A Morning-to-Night Guide to Optimal Timing
Many people take whatever supplements they missed earlier in the day right before bed or wash them down with morning...
Pack More Than a Passport: The Essential Guide to Travel Vaccines and Malaria Prevention
If you have already packed your bags for peak vacation season, it is still too early to completely relax.
Beyond the 'Miracle Cure' Myth: Why Early Detection Remains Our Strongest Weapon Against Cancer
The number of cancer diagnoses in South Korea is rising sharply, and warnings about growing case counts are no longer a...
The Probiotic Paradox: Why Your Daily Supplement Might Never Reach Your Gut
These days, millions of people jumpstart their morning routines by reaching for a daily dose of probiotics.
High Blood Pressure After Childbirth: Why the Cardiovascular Risks of Preeclampsia Don't End at Delivery
"They told me my blood pressure was a bit high during pregnancy, but doesn’t it go back to normal after I give birth.
Jennie vs. Rosé: The Nutritional Secrets Behind the BLACKPINK Physique
Jennie and Rosé, members of the world-renowned group BLACKPINK, recently sparked a conversation on social media by...
SK Chemicals Launches High-Dose 300 mg Joins for Osteoarthritis Treatment
SK Chemicals has announced the release of a new high-dose version of Joins, its flagship natural product-based...